Conference Coverage

CKD triples risk of bad outcomes in HIV


 

REPORTING FROM CROI


The subjects were all participants in the D:A:D project [Data Collection on Adverse Events of Anti-HIV Drugs], an ongoing international cohort study based at the University of Copenhagen, and funded by pharmaceutical companies, among others.

Dr. Ryom had no disclosures.

SOURCE: Ryom L et al. CROI, Abstract 75.

Pages

Recommended Reading

Antiretroviral choice for pregnant women with HIV does not appear to impact birth outcomes
MDedge Infectious Disease
HIV infection linked to higher risk of non-melanoma skin cancer
MDedge Infectious Disease
Most HIV patients need treatment for acute HCV
MDedge Infectious Disease
New trial to assess HIV+/HIV+ kidney transplants
MDedge Infectious Disease
Emotional regulation training lowers risk of adolescents having sex
MDedge Infectious Disease
Make the Diagnosis - May 2018
MDedge Infectious Disease
FDA seeks comments on pediatric HIV product development
MDedge Infectious Disease
FDA approves epoetin alfa biosimilar to treat anemia
MDedge Infectious Disease
FDA: PrEP indication updated to include adolescents at risk of HIV infection
MDedge Infectious Disease
FDA warns of birth defect risks from dolutegravir
MDedge Infectious Disease